SEBI new F&O trading norms: Zerodha to review pricing after November 20, says CEO Nithin Kamath

  • Nithin Kamath, co-founder and CEO of Zerodha, announced that the leading online stock brokerage platform will review its pricing structure after November 20, 2024, based on the impact of new rules for index derivatives trading.

Nikita Prasad
Published4 Oct 2024, 10:47 PM IST
Trade Now
Nithin Kamath. CEO and co-founder of Zerodha
Nithin Kamath. CEO and co-founder of Zerodha

Capital markets regulator Securities and Exchange Board of India (SEBI) has mandated a new framework for India's booming equity derivates market and announced sweeping changes to curb the rush in futures and options (F&O) trading. Post-SEBI's announcement of new F&O norms, Nithin Kamath, co-founder and CEO of Zerodha, announced that the leading online stock brokerage platform will review its pricing structure after November 20, 2024, based on the impact of new rules for index derivatives trading.

Taking to microblogging platform ‘X’ (formerly Twitter) X, Zerodha's Kamath said, “Here's the potential impact of only one weekly expiry of index derivatives per exchange and contract sizes going up by around 2.5 times.”

Also Read: ‘SEBI changes F&O game, not a bad idea on expiry day’: Capitalmind’s Deepak Shenoy on new derivates framework

“As things stand, assuming that those trading weekly don't move on to trading monthly, the impact will be ~60 per cent of overall F&O trades and ~30 per cent of our overall orders. I guess things will become much clearer from November 20th. We will then decide on our change in pricing structure, based on the impact on the business,” said Kamath in a post on ‘X’.

SEBI implemented six out of seven measures recommended by an expert panel to cool the exuberance in India's derivatives market. Market participants said the measures, which will be implemented in phases, could dent derivatives volumes by 20-30 per cent.

Out of the six, the ones that could impact volumes the most are the reduction in weekly expiries per exchange from five to just one, the increase in lot size to 15-20 lakh from 5-10 lakh, and the removal of the calendar spread benefit on expiry day. The first two will take effect on November 20, and the third on February 1, 2025.

Also Read: SEBI approves new asset class for HNIs, passive fund framework; rights issue timeline slashed: 5 key highlights

This means that weekly expiries are limited to one per exchange, and contract sizes are increased. As a result, the contract size for index F&O will rise from 5-10 lakh to 15-20 lakhs. From November 20, stock exchanges can offer weekly expiries for only one benchmark index. For example, the NSE can choose between Nifty 50 or Bank Nifty, but not both. All other indexes will move to monthly expiries.

Additionally, starting in February 2025, traders will lose margin benefits on calendar spreads for contracts expiring on expiry day, increasing margin requirements for many. SEBI has also introduced an Extreme Loss Margin (ELM) of two per cent on expiry day to cover risks due to heightened volatility.

Also Read: Stock Market Crash: Israel-Iran war to FII outflows—5 reasons why Sensex, Nifty plunged today amid volatility

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:4 Oct 2024, 10:47 PM IST
Business NewsMarketsStock MarketsSEBI new F&O trading norms: Zerodha to review pricing after November 20, says CEO Nithin Kamath

Most Active Stocks

Tata Steel share price

155.25
03:58 PM | 16 OCT 2024
-0.4 (-0.26%)

Tata Power share price

460.35
03:58 PM | 16 OCT 2024
-3.15 (-0.68%)

Bharat Petroleum Corporation share price

350.85
03:57 PM | 16 OCT 2024
1.65 (0.47%)

Bharat Electronics share price

285.65
03:49 PM | 16 OCT 2024
-3.15 (-1.09%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Coforge share price

7,120.75
10:51 AM | 7 OCT 2024
-2.4 (-0.03%)

Vijaya Diagnostic Centre share price

984.80
10:51 AM | 7 OCT 2024
-4.15 (-0.42%)

Dr. Lal Pathlabs share price

3,408.00
10:50 AM | 7 OCT 2024
-86.25 (-2.47%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,519.95
10:51 AM | 7 OCT 2024
-245.3 (-8.87%)

Jubilant Ingrevia share price

728.55
10:51 AM | 7 OCT 2024
-65.7 (-8.27%)

Triveni Engineering & Indus share price

426.65
10:51 AM | 7 OCT 2024
-35.75 (-7.73%)

Vodafone Idea share price

9.08
10:51 AM | 7 OCT 2024
-0.72 (-7.35%)
More from Top Losers

Astrazeneca Pharma India share price

7,832.35
10:51 AM | 7 OCT 2024
399.85 (5.38%)

Finolex Industries share price

280.85
10:51 AM | 7 OCT 2024
9.2 (3.39%)

Macrotech Developers share price

1,206.20
10:51 AM | 7 OCT 2024
34.35 (2.93%)

JK Lakshmi Cement share price

797.60
10:51 AM | 7 OCT 2024
17.2 (2.2%)
More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,405.000.00
      Chennai
      77,411.000.00
      Delhi
      77,563.000.00
      Kolkata
      77,415.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Markets

        HomeMarketsPremiumInstant LoanMint Shorts